RP Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

RP Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,111,111	Closed	-$168M	–	4
2022 Q3	$168M	Hold	1,111,111	–	–	77.6%	1
2022 Q2	$162M	Hold	1,111,111	–	–	64.91%	1
2022 Q1	$132M	Hold	1,111,111	–	–	54.43%	1
2021 Q4	$153M	Hold	1,111,111	–	–	65.85%	1
2021 Q3	$154M	Hold	1,111,111	–	–	76.67%	1
2021 Q2	$108M	Sell	1,111,111 -1,000,000	-47%	-$81.2M	58.6%	1
2021 Q1	$144M	Hold	2,111,111	–	–	59.01%	1
2020 Q4	$181M	Hold	2,111,111	–	–	60.57%	1
2020 Q3	$137M	Hold	2,111,111	–	–	21.53%	2
2020 Q2	$154M	Hold	2,111,111	–	–	32.34%	2
2020 Q1	$71.8M	Hold	2,111,111	–	–	25.35%	2
2019 Q4	$115M	Hold	2,111,111	–	–	30.18%	2
2019 Q3	$88.1M	Hold	2,111,111	–	–	56.41%	1
2019 Q2	$92.4M	Hold	2,111,111	–	–	56.7%	1
2019 Q1	$109M	Hold	2,111,111	–	–	54.35%	1
2018 Q4	$78.1M	Buy	+2,111,111	New	+$76.1M	53.45%	1

Other funds holding BHVN

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return